Press Releases about Gilead Sciences
Exposures
COVID-19
![](https://mms.businesswire.com/media/20230918133960/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230918072814_can-these-3-healthcare-dividend-stocks-deliver-inc.jpg)
![](https://mms.businesswire.com/media/20230918662167/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
September 13, 2023
Exposures
Product Safety
![](https://mms.businesswire.com/media/20230909895203/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230907463986/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Prices $2 Billion of Senior Unsecured Notes
September 07, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230823245751/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230823013787/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences to Present at Upcoming Investor Conferences
August 23, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230820242621/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230816668295/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230814981551/en/1867352/22/Tentarix_logo.jpg)
![](https://mms.businesswire.com/media/20230802165242/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences Announces Second Quarter 2023 Financial Results
August 03, 2023
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20230727124843_7-best-cancer-stocks-to-invest-in-now.jpg)
![](https://mms.businesswire.com/media/20230726933349/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230724915750/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230723794099/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230720298935/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230721916957/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230720619841/en/1846139/5/CDAF_Logo_Horizontal_1686x800.jpg)
![](https://mms.businesswire.com/media/20230719021635/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://ml.globenewswire.com/media/26c37367-6d70-48af-b8d2-e9ca1c399cb6/small/cdaf-logo-horizontal-211x100-jpg.jpg)
![](https://mms.businesswire.com/media/20230719263471/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
![](https://mms.businesswire.com/media/20230714408028/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230713562695/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230713072449_gilead-boosts-biotech-footprint-with-stakes-in-all.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.